Feifei Qi

4.4k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Feifei Qi is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Feifei Qi has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Feifei Qi's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). Feifei Qi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). Feifei Qi collaborates with scholars based in China, United States and Japan. Feifei Qi's co-authors include Chuan Qin, Linlin Bao, Shuwen Liu, Yun Zhu, Shibo Jiang, Wei Xu, Zheng‐Li Shi, Shuai Xia, Chao Wang and Lu Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Feifei Qi

30 papers receiving 1.6k citations

Hit Papers

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Qi China 16 889 589 208 170 170 33 1.6k
Gururao Hariprasad India 16 648 0.7× 682 1.2× 139 0.7× 79 0.5× 172 1.0× 54 1.6k
Martina Geier Austria 19 1.3k 1.4× 973 1.7× 320 1.5× 257 1.5× 76 0.4× 31 2.5k
Suresh Kumar Malaysia 24 542 0.6× 877 1.5× 177 0.9× 201 1.2× 111 0.7× 90 1.9k
Ahmad Abu Turab Naqvi India 13 611 0.7× 518 0.9× 76 0.4× 59 0.3× 288 1.7× 23 1.3k
Chufang Li China 21 567 0.6× 557 0.9× 275 1.3× 470 2.8× 96 0.6× 45 1.7k
Xiuyuan Ou China 11 1.9k 2.1× 596 1.0× 260 1.3× 194 1.1× 210 1.2× 21 2.5k
Siliang Feng China 10 769 0.9× 452 0.8× 119 0.6× 107 0.6× 164 1.0× 16 1.2k
Young-Hee Jin South Korea 22 373 0.4× 405 0.7× 440 2.1× 225 1.3× 114 0.7× 82 1.5k
Zhigang Wu China 24 615 0.7× 1.1k 1.8× 210 1.0× 109 0.6× 33 0.2× 69 2.4k
Tieshan Teng China 12 426 0.5× 392 0.7× 180 0.9× 131 0.8× 77 0.5× 34 1.3k

Countries citing papers authored by Feifei Qi

Since Specialization
Citations

This map shows the geographic impact of Feifei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Qi more than expected).

Fields of papers citing papers by Feifei Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Qi. The network helps show where Feifei Qi may publish in the future.

Co-authorship network of co-authors of Feifei Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Qi. A scholar is included among the top collaborators of Feifei Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Qi. Feifei Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Feifei, et al.. (2025). Targeted-release budesonide: A comprehensive review on its potential in IgA nephropathy. Heliyon. 11(4). e42729–e42729.
2.
Bao, Linlin, et al.. (2025). ILC3 Function as a Double-Edged Sword in EV71 Infection. Viruses. 17(2). 184–184. 1 indexed citations
3.
Zhang, Yaqing, Qi Lv, Feifei Qi, et al.. (2023). Comparison of the replication and neutralization of different SARS‐CoV‐2 Omicron subvariants in vitro. SHILAP Revista de lepidopterología. 6(1). 51–56. 4 indexed citations
4.
Xun, Hang, et al.. (2023). Chemical Constituents of the Mushroom Dictyophora indusiata and Their Anti-Inflammatory Activities. Molecules. 28(6). 2760–2760. 16 indexed citations
5.
Chen, Zhe, Linlin Bao, Bin Zhu, et al.. (2022). Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71. Science China Life Sciences. 65(12). 2517–2526.
6.
Qi, Feifei, Wei Zhang, Yingying Xue, et al.. (2022). Microbial production of the plant-derived fungicide physcion. Metabolic Engineering. 74. 130–138. 17 indexed citations
7.
Song, Zhiqi, Linlin Bao, Pin Yü, et al.. (2021). SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters. Frontiers in Microbiology. 11. 618891–618891. 43 indexed citations
8.
Li, Fengwei, Li Ma, Xingwang Zhang, et al.. (2020). Structure-guided manipulation of the regioselectivity of the cyclosporine A hydroxylase CYP-sb21 from Sebekia benihana. Synthetic and Systems Biotechnology. 5(3). 236–243. 4 indexed citations
9.
Xia, Shuai, Meiqin Liu, Chao Wang, et al.. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Research. 30(4). 343–355. 978 indexed citations breakdown →
10.
Xu, Huifang, Yuanyuan Jiang, Wenxia Yang, et al.. (2019). Directed Evolution of P450 Fatty Acid Decarboxylases via High‐Throughput Screening towards Improved Catalytic Activity. ChemCatChem. 12(1). 80–84. 20 indexed citations
11.
Zhang, Wei, Lei Du, Zepeng Qu, et al.. (2019). Compartmentalized biosynthesis of mycophenolic acid. Proceedings of the National Academy of Sciences. 116(27). 13305–13310. 69 indexed citations
12.
Gong, Shuran, Feifei Qi, Fengdi Li, et al.. (2019). Human-Derived A/Guangdong/Th005/2017 (H7N9) Exhibits Extremely High Replication in the Lungs of Ferrets and Is Highly Pathogenic in Chickens. Viruses. 11(6). 494–494. 3 indexed citations
13.
Qi, Feifei, Chao Lei, Fengwei Li, et al.. (2018). Deciphering the late steps of rifamycin biosynthesis. Nature Communications. 9(1). 2342–2342. 32 indexed citations
14.
Ji, Tianjiao, Jiayan Lang, Bo Ning, et al.. (2018). Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes. Advanced Materials. 31(6). e1804395–e1804395. 72 indexed citations
15.
Fang, Bo, Dongfei Han, Wenxia Yang, et al.. (2016). Improving the Secretory Expression of an α-Galactosidase from Aspergillus niger in Pichia pastoris. PLoS ONE. 11(8). e0161529–e0161529. 15 indexed citations
16.
Du, Lei, Li Ma, Feifei Qi, et al.. (2016). Characterization of a Unique Pathway for 4-Cresol Catabolism Initiated by Phosphorylation in Corynebacterium glutamicum. Journal of Biological Chemistry. 291(12). 6583–6594. 37 indexed citations
17.
Su, Jing, et al.. (2014). A modified GEWF solution is cost-saving and effective for lymph node retrieval in resected colorectal carcinoma specimens. Pathology - Research and Practice. 210(9). 543–547. 5 indexed citations
18.
He, Ting, Feifei Qi, Lin Jia, et al.. (2014). MicroRNA‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2. The Journal of Pathology. 232(5). 499–508. 84 indexed citations
19.
Zeng, Sheng, Jianqi Wu, Jing Liu, et al.. (2014). Infection with respiratory syncytial virus influences FasL-mediated apoptosis of pulmonary γδ T cells in a murine model of allergen sensitization. Journal of Asthma. 51(4). 360–365. 4 indexed citations
20.
Liu, Jing, Jianqi Wu, Bing Wang, et al.. (2013). Oral vaccination with a liposome‐encapsulated influenza DNA vaccine protects mice against respiratory challenge infection. Journal of Medical Virology. 86(5). 886–894. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026